Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:SNCE

Science 37 (SNCE) Stock Price, News & Analysis

Science 37 logo

About Science 37 Stock (NASDAQ:SNCE)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$5.75
$5.75
50-Day Range
$5.68
$5.75
52-Week Range
$3.73
$12.96
Volume
N/A
Average Volume
43,227 shs
Market Capitalization
$34.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.

Remove Ads
Receive SNCE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Science 37 and its competitors with MarketBeat's FREE daily newsletter.

SNCE Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

SNCE Stock Analysis - Frequently Asked Questions

Shares of Science 37 reverse split on Friday, December 8th 2023. The 1-20 reverse split was announced on Friday, December 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Science 37 investors own include Meta Platforms (META), NVIDIA (NVDA), Sangamo Therapeutics (SGMO), Broadcom (AVGO), Builders FirstSource (BLDR), Adobe (ADBE) and Advanced Micro Devices (AMD).

Company Calendar

Today
3/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
NASDAQ:SNCE
Fax
N/A
Employees
460
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-50,990,000.00
Net Margins
-206.86%
Pretax Margin
-207.00%

Debt

Sales & Book Value

Annual Sales
$60.26 million
Price / Cash Flow
N/A
Book Value
$16.70 per share
Price / Book
0.34

Miscellaneous

Free Float
5,564,000
Market Cap
$34.33 million
Optionable
Not Optionable
Beta
0.55
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:SNCE) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners